Research Article
Open Access
C-to-U RNA deamination is the driving force accelerating SARS-CoV-2 evolution
Yan Li, Fanghua Hou, Meili Zhou, Xiaoping Yang, Bin Yin, View ORCID ProfileWenqing Jiang, View ORCID ProfileHuiqing Xu Correspondence email
Yan Li
1Cardiovasology Department I, Qingdao Center Hospital, Qingdao, China
Roles: formal analysis, visualization
Fanghua Hou
1Cardiovasology Department I, Qingdao Center Hospital, Qingdao, China
Roles: formal analysis, visualization
Meili Zhou
2Emergency Department, Qingdao Center Hospital, Qingdao, China
Roles: formal analysis, visualization
Xiaoping Yang
3Department of Respiratory Diseases, Qingdao Haici Hospital, Qingdao, China
Roles: formal analysis, visualization
Bin Yin
3Department of Respiratory Diseases, Qingdao Haici Hospital, Qingdao, China
Roles: formal analysis, visualization
Wenqing Jiang
3Department of Respiratory Diseases, Qingdao Haici Hospital, Qingdao, China
Roles: conceptualization, supervision
Huiqing Xu
4Department of Pathology, Qingdao Haici Hospital, Qingdao, China
Roles: conceptualization, supervision
Published 8 November 2022. DOI: 10.26508/lsa.202201688
Novel mutation rate in SARS-CoV-2
Yan Li, Fanghua Hou, Meili Zhou, Xiaoping Yang, Bin Yin, Wenqing Jiang, Huiqing Xu
Life Science Alliance Nov 2022, 6 (1) e202201688; DOI: 10.26508/lsa.202201688
In this Issue
Volume 6, No. 1
January 2023
Advertisement
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.